Jury out on thiopurine & COVID-19 risk in IBD

While the evidence is still scarce, gastroenterologists can be reasonably hopeful that the use of thiopurine in IBD patients should not increase their COVID-19 risk. In a preprint version of a MJA article, South Australian gastroenterologists Dr Thomas Goodsall, Dr Sam Costello and Dr Rob Bryant said thiopurine use has previously been associated with an ...

Already a member?

Login to keep reading.

© 2021 the limbic